health_en | Page 121 of 128

TCAI physicians participate in clinical trial for potential life-saving device for patients with heart rhythm disorders

Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center are among the first in the world to participate in a clinical trial to evaluate a new esophageal protection device designed to make ablation procedures safer for patients with atrial fibrillation (A Fib), the most common type of cardiac arrhythmia. Andrea Natale, M.D., F.H.R.S., F.A.C.C., […]

5 ก.พ. 64 11:30

thaipr.net

5 ก.พ. 64

IHME extends COVID-19 forecasts to June 1, predicting over 3.5 million deaths globally

Rapid vaccination rollout, mask wearing crucial to control spread The latest COVID-19 forecasts from the Institute for Health Metrics and Evaluation at the University of Washington School of Medicine predict more than 3.5 million deaths globally by June 1. The United States is expected to see a death toll of 631,000 by June 1. Increasing […]

5 ก.พ. 64 9:30

thaipr.net

5 ก.พ. 64

Global survey presented at the Digital Liver Cancer Summit 2021 reveals heavy toll of COVID-19 first wave on liver cancer care

Digital Liver Cancer Summit 2021: A global survey assessing the impact of COVID-19 on liver cancer has revealed delays in the screening, diagnosis, and treatment of the disease, with experts issuing stark warnings on liver cancer survival rates. The delays of screening programmes, diagnostic imaging and biopsies, cuts in the numbers of physicians available to […]

5 ก.พ. 64 8:55

thaipr.net

5 ก.พ. 64

Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, for the treatment of patients with glioblastoma. GLR2007 is a cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor that Gan & Lee […]

5 ก.พ. 64 8:30

thaipr.net

5 ก.พ. 64

NCCN Gets Personal About Improving Global Cancer Care for World Cancer Day

Nonprofit alliance behind gold standard oncology guidelines shares stories of personal connections to cancer that inspire many within the organization. Global oncology community looks at the impact from COVID-19 on cancer care over the past year. The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—joins people and organizations worldwide in commemorating World Cancer […]

4 ก.พ. 64 8:30

thaipr.net

4 ก.พ. 64

Mindray Launches New BeneFusion e Series Infusion Systems, Delivering Efficiency in Every Droplet

Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, has unveiled its BeneFusion e Series, a revolutionary efficient infusion system for the healthcare industry. Available in three models, eSP, eVP and eDS, the BeneFusion e Series delivers efficiency in workflow, safety, application and informatics. This brand-new series will be available in […]

3 ก.พ. 64 9:05

thaipr.net

3 ก.พ. 64

Globally unique MRI Guarantee: The highest MRI safety with hearing implants from MED-EL

Worry-free, safe magnetic resonance imaging (MRI) with MED-EL cochlear, middle ear or bone conduction implants – now with lifetime guarantee. For immediate access to an MRI examination without surgery, discomfort or hearing downtime. The innovative design of the implant magnets from MED-EL is completely safe during an MRI examination. As of now, the global innovation […]

2 ก.พ. 64 14:30

thaipr.net

2 ก.พ. 64

CF PharmTech and Chengdu Shangyi Launch the “Home-Based Recovery Program for Discharged Covid-19 Patients” and Announce Today’s Global Release of the “R Plus Health” Free App

CF PharmTech, Inc. is a fully integrated pharmaceutical company in China specializing in the treatment of respiratory diseases. Chengdu Shangyi Information Technology Co., Ltd is a professional IT…

2 ก.พ. 64 9:402021-02-02

thaipr.net

2 ก.พ. 64

Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants

– SEEGENE ROLLS OUT FIRST COVID-19 MUTANT IDENTIFICATION TEST– COVID-19 TEST MANUFACTURER CONTINUES TRACKING VARIANTS– S. KOREAN FIRM COMMITTED TO WORKING WITH GOVERNMENTS South Korea’s biotechnology firm Seegene (KQ096530) said Monday it developed the world’s first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction. Seegene’s new…

1 ก.พ. 64 13:10

thaipr.net

1 ก.พ. 64

Alfasigma to expand its digital footprint

Online doctorAsyou, a web platform entirely dedicated to physicians The website optimizes research on the most important and autoritative medical databases such as Pubmed, ICTRP and ClinicalTrials.gov. An entirely new area presents online courses for physicians on several different topics Alfasigma has recently launched a number of digital activities that expand its web presence and […]

1 ก.พ. 64 9:00

thaipr.net

1 ก.พ. 64